SkyKnight Capital announced the close of its fifth fund, SkyKnight Capital Fund V, with $2 billion in commitments, marking another milestone in its investment strategy.

Founded in 2015, the firm has offices in Burlingame, California and New York, and focuses on healthcare and several other sectors, positioning itself as a niche private equity player.

The firm targets investments ranging from $25 million to $250 million or higher, seeking equity stakes between 25% and 75% or greater, with a flexible approach to ownership.

Trey is a national practice representative who serves private equity funds, independent sponsors, family offices, high‑net‑worth individuals, and other investors and private companies, offering expertise in mergers & acquisitions, joint ventures, minority investments, and corporate and regulatory matters across healthcare, health & wellness, consumer products & retail, sports, and food & drug sectors.

The $2 billion fund underscores SkyKnight’s confidence in the healthcare sector’s growth prospects and its ability to deploy capital efficiently. With a track record of successful deals, the firm is poised to continue delivering value to its investors and portfolio companies.